UNSPSC 51352003: Gestonorone

This classification denotes a therapeutic progestin with the molecular formula C20H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H4G605B7VP, chemically known as 19-norpregn-4-ene-3,20-dione, 17-hydroxy- but generally known as gestonorone, which bears US NIH Compound Identifier 102210. European Medicines Agency schedules Gestonorone caproate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07902MIG.

UNSPSC 51352003 Gestonorone is a Commodity code covering synthetic pharmaceutical products sold through state and local health care procurement channels. State and local governments procure generic pharmaceuticals and over-the-counter products under this code through cooperative purchasing vehicles and direct solicitations, typically for distribution across participating state facilities, local government health departments, schools, and other public health agencies.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon. Awarded vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and maintain contractual relationships with at least two of the three. Evaluation weights pricing competitiveness at 75 percent, with the remainder distributed across fixed pricing, administrative fee format compliance, EDI capability, and acceptance of a 3 percent administrative fee. Vendors must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain comprehensive insurance including $5,000,000 commercial general liability, and provide products with expiration dates of at least one year from manufacture. The contract term is two years for new vendors, with optional extensions at MMCAP's discretion; awarded vendors will be provided to wholesalers by May 15, 2026, with resulting agreements effective July 1, 2026. Performance penalties range from $200 to $1,500 per violation for issues such as late reporting or missed onboarding timelines.